ABSTRACT
Hypertensive disorder in pregnancy is on the rise in today's world which is among one of the leading causes of both the maternal and perinatal morbidity and mortality [1] [2] [3] . In the developed countries, it ranked as the most common cause of maternal and perinatal morbidity and mortality, where as in developing countries anemia is still the most common. Systolic blood pressure reading of more than 140 mmHg and a diastolic pressure of more than 90 mmHg obtained at 6 hours interval after 20 weeks period of gestation is termed as hypertensive disorder in pregnancy. The acute elevation of blood pressure in pregnancy had several maternal complications like convulsions, abruptions, HELLP syndrome, hepatic and renal failure, retinal detachment and also rises the risk of heart attacks, cardiac failure, cerebrovascular accidents of the mother. Fetal complication is mainly due to the abnormal blood circulation from the mother to the fetus, which reduces the oxygen transfer to the fetus leading to condition like IUGR, premature delivery, foetal hypoxia to stillbirth, and higher rate of neonatal death 2 . Hypertension in pregnancy along with bleeding and infection are the most common causes of maternal mortality and morbidity [4] [5] [6] [7] .
The American College of Obstetricians and Gynecologists (ACOG) and National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy has classified the hypertensive disorder in pregnancy into four major groups: 1) Gestational hypertension, where resting BP is 140/90 mmHg or higher after the 20 week of gestation, 2) Chronic hypertension, that exists before pregnancy or begins in the first 20 weeks of gestation, 3) Preeclampsia (raised BP and edema or proteinuria)/eclampsia (preeclampsia and seizures), 4) Preeclampsia superimposed on chronic hypertension 3, 4, 8, 9 . The pathology, clinical presentation and the outcome varies greatly with each category of cases 10 .
In spite of the very high incidence of the hypertensive disorder, even today the cause of the disease remains an unsolved one. After a very extensive clinical research, the cause is attributed to be immunological. This theory states that the abnormal trophoblastic invasion of the placenta, leads to the secretion of certain substances that activate vascular endothelial cells and damages them. These secretions have a vasoconstriction effect on all the systemic blood vessels leading to the rise of blood pressure.
Hypertensive disorder is more common among the nulligravidas and elderly women. Among the elderly women more so being the chronic hypertension superimposed by preeclampsia. It is a progressive disorder, which initiates at fertilization and courses until the total expulsion of the placenta. The changes occurring in the body will progress to a state of multi organ involvement increasing the mortality and morbidity in both the mother and the fetus 4 .
Medical management of the hypertensive disease does not prevent the fetal prognosis but studies have proven that early detection of the disease and treatment decreases both the hypertensive crises in the mother and reduces fetal complications. The use of antihypertensive is to prolong the pregnancy and slow down the progression of the disease until the period of viability reached in the fetus not compromising the mother. The choice of the antihypertensive is a challenge during pregnancy, and the dose calculation is difficult due to the physiological changes of pregnancy and the pathological changes of the disease. The commonly used drugs in pregnancy are methyldopa, beta-blockers, calcium channel blockers and vasodilators. Labetalol tops the chart, methyldopa is the oldest drug, which has been available for many years and is widely used. Studies support the use of betablockers and calcium channel blockers used in essential hypertension in pregnancy 11 .
Antihypertensive drug use during pregnancy is relatively common and increasing today, but the choice of which antihypertensive drug is less complex as only a small proportion of presently available drugs have been evaluated completely on pregnant women and many are contraindicated 12 . The objective of this study was to identify the prevalence of the hypertensive disorder, the contributor and associated factors, maternal and fetal outcome.
Materials and Methods
The study was performed at the ESIC PGIMSR and Model Hospital, a tertiary care center, Bangalore. This is a retrospective study, which included 286cases, studied over a period of 1 year from January 2016 to December 2016. Hypertension was identified based on the definition by the National Working Group Report on High Blood Pressure in Pregnancy, a recorded blood pressure of > 140/90 mmHg. Based on the signs and symptoms of the disease and a past history of hypertension before pregnancy, the patients were classified into the following groups of gestational hypertension, chronic Hypertension, preeclampsiaeclampsia and preeclampsia superimposed on chronic hypertension and eclampsia. The various data regarding demographic details, presenting complaints, gestational age, obstetrics history, diagnosis, blood pressure monitoring, current medications, antihypertensive drugs prescribed were gathered from medical record files. The collected data were tabulated and analyzed in SPSS software.
Results
Of the total 3250 women delivered in the hospital 286 had hypertension (8.8%). Two hundred thirty (80.4%) women fell in the age group of 21 -30 years (53) cases. The commonly used antihypertensive was beta-blockers followed by calcium channel blockers.
Discussion
Hypertensive disorder in pregnancy even today continues to be a major problem in pregnant women even after extensive research. American Society of Nephrology reported an increased prevalence in preeclampsia in a rural area in developing countries 13 .
Adverse maternal and fetal outcome associated with hypertension complicating pregnancy can be prevented by regular antenatal visits. Roberts et al. studied 250 women with hypertensive disorder in pregnancy and they reported the prevalence to be 9.8%, 0.6% of which had chronic hypertension, 4.2% were diagnosed as preeclampsia, 0.3% women had preeclampsia superimposed on chronic hypertension, and 4.3% had gestation hypertension 14 .
Whereas another study conducted in Nigeria, reported 5.3% of the population to be affected by hypertension complicating pregnancy, gestational hypertension, preeclampsia superimposed on chronic hypertension and preeclampsia-eclampsia were noted in 54.1%, 26.2% and 19.7% respectively 15 . In this study we report the prevalence to be 8.8%,80.06% had gestational hypertension, 14.68% had preeclampsiaeclampsia, 0.34% had preeclampsia superimposed on chronic hypertension, 2.79% had chronic hypertension and 2.09% had eclampsia. The highest prevalence of the disorder was noted among the women <20 and > 32 years and among the primigravidas which was similar to the results obtained by Shahla et al 16 . Yadav et al. 17 concluded that the risk of PIH was higher when the age of pregnant women was less than 25 years, and this observation was in similarity with ours. A study by Mohanty et al 18 reported that primiparous patients with PIH below 20 years of age was in 26% but only 15% of the controls were less than 20 years. In this study, we observed the systolic blood pressure ranged between 140 to 230 and diastolic ranged from 90 to 140 mmHg, mean blood pressure being 185 and 115 for systolic and diastolic respectively. Similar results were noted in a study conducted by Buga et al in which included a total of 760 women, with an average blood pressure of 163.0/108.8 mmHg, systolic pressure ranged from 140 to 270 mmHg, and diastolic from 90 to 190 mmHg 19 .
Placental abruption was noted in 1.74% of the women in this study which was relatively similar to 2% noted by Eshetu et al 20 , in contrast to a study by Hall et al conducted by which reported as high as 20% 21 .
HELLP syndrome was noted in 4.54% which was much lesser than 12.4% of the cases noted by Eshetuet al. 20 and Prakash et al. reported HELLP syndrome in 7.5% of cases of preeclampsia 22 .
The fetal outcome was noted in the form of preterm deliveries, Apgar score, intrauterine growth restriction, low birth weight, the need for neonatal resuscitation, admission to neonatal intensive care unit and intrauterine fetal demise. Incidence of preterm delivery noted in 28.67%, intrauterine growth restriction found in 14.68% of births, low birth weight in 26.57% and intrauterine fetal demise in 2.09. A study by Yadav et al. reported preterm deliveries in 28.8% which was similar to our result but a higher IUFD of 4.8% 17 . In this study, we noted 27.97% mothers had vaginal delivery, and higher percentage (71.32%) underwent cesarean section. Pregnancy was terminated by induction in 53.8% cases, 47.05% of whom had cesarean delivery. Elective cesarean delivery was performed in 18.53% cases.
Conclusion
Hypertension in pregnancy is associated with multiple and complicated complications in both the mother and baby. Presently screening modalities help early detection of the diseases and timely intervention of hypertensive disorders complicating pregnancy and provision of specialized systemic antenatal maternal care could reduce the impacts of such complications.
